Nureca's Q3 FY 2025-26 Quarterly Results
- 2d ago
Result Summary
- Nureca Ltd reported a 4.4% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 49.7%.
- Its expenses for the quarter were up by 4.8% QoQ and 19.1% YoY.
- The net profit increased 2.8% QoQ and decreased 233.2% YoY.
- The earnings per share (EPS) of Nureca Ltd stood at 3.91 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 41.83 | 40.06 | 27.94 | 4.4% | 49.7% |
Total Expenses | 37.17 | 35.47 | 31.20 | 4.8% | 19.1% |
Profit Before Tax | 4.66 | 4.60 | -3.25 | 1.3% | -243.4% |
Tax | 0.93 | 0.97 | -0.45 | -4.1% | -306.7% |
Profit After Tax | 3.73 | 3.63 | -2.80 | 2.8% | -233.2% |
Earnings Per Share | 3.91 | 3.63 | -2.80 | 7.7% | -239.6% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Nureca Ltd is a company that specializes in the design, development, and distribution of healthcare and wellness products. The company operates within the broader healthcare and wellness industry, focusing on innovative solutions that enhance the quality of life for its customers. Nureca Ltd's product range typically includes medical devices, nutrition supplements, and lifestyle products tailored to consumer needs. The company's commitment to innovation and quality has positioned it as a notable player in its market segment. Information on recent major developments for Nureca Ltd is not available, and it is essential to note that the company's strategic direction and market positioning are subject to industry dynamics and consumer preferences.
Revenue
In the third quarter of the fiscal year 2026 (Q3FY26), Nureca Ltd reported a total income of ₹41.83 crores. This marks a 4.4% increase compared to its income of ₹40.06 crores in the second quarter of fiscal year 2026 (Q2FY26). When compared to the same quarter in the previous fiscal year (Q3FY25), where the total income was ₹27.94 crores, there is a significant year-over-year (YoY) increase of 49.7%. This substantial growth in revenue in both the quarter-over-quarter (QoQ) and YoY perspectives highlights an upward trajectory in the company's income generation capabilities over the past year.
Profitability
Nureca Ltd's profitability metrics for Q3FY26 reveal a Profit Before Tax (PBT) of ₹4.66 crores, which shows a 1.3% increase from the ₹4.60 crores reported in Q2FY26. When compared to Q3FY25, where the company recorded a loss of ₹3.25 crores, the YoY change is substantial, marking a turnaround in profitability by 243.4%. After accounting for taxes, the Profit After Tax (PAT) for Q3FY26 is ₹3.73 crores, a 2.8% rise from the previous quarter's PAT of ₹3.63 crores. This is a significant improvement from the PAT loss of ₹2.80 crores in Q3FY25, reflecting a YoY increase of 233.2%. The Earnings Per Share (EPS) for Q3FY26 is ₹3.91, compared to ₹3.63 in Q2FY26, representing a 7.7% QoQ growth and a striking improvement from the negative EPS of ₹2.80 in Q3FY25, which translates to a 239.6% YoY increase.
Operating Metrics
The total expenses for Nureca Ltd in Q3FY26 amounted to ₹37.17 crores, reflecting a 4.8% increase from ₹35.47 crores in Q2FY26. On a YoY basis, total expenses increased by 19.1% from ₹31.20 crores reported in Q3FY25. The tax expense for Q3FY26 is recorded at ₹0.93 crores, showing a slight decrease of 4.1% from ₹0.97 crores in Q2FY26. Compared to Q3FY25, where the tax expense was a negative ₹0.45 crores, the YoY change is substantial at 306.7%. These operating metrics underline the cost structure and tax obligations impacting the company's financial performance across different periods.